nondigestible oligosaccharide
Botanicalexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2001 (NCT00022867)
Timeline
2000s
- Jan 1, 2001
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nondigestible oligosaccharide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05378295 | N/A | Nov 5, 2021 | Maastricht University |
| NCT04767672 | N/A | Mar 31, 2021 | Biofortis, Tereos |
| NCT00022867 | Phase 1/Phase 2 (Phase 2) | May 1, 2001 | Baylor University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2001 |
| Biofortis | For profit | 1 | 0 | 1 | 2021 |
| Maastricht University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Government | 1 | 0 | 1 | 2001 |
| Tereos | For profit | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1